# FDA Inspection 1268717 - Vitalant - April 22, 2025

Source: https://www.keypedia.com/records/fda_inspections/vitalant/b032afdb-b99f-49ce-b171-b4b361ba288e
Source feed: FDA_Inspections

> FDA Inspection 1268717 for Vitalant on April 22, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1268717
- Company Name: Vitalant
- Inspection Date: 2025-04-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1268717 - 2025-04-22](https://www.keypedia.com/records/fda_inspections/vitalant/d7380b7c-2788-41b7-af79-8e3ff6855a45)
- [FDA Inspection 1170412 - 2022-05-19](https://www.keypedia.com/records/fda_inspections/vitalant/1684c57b-be6a-4e73-b6de-bbb37b23aa6d)
- [FDA Inspection 1058211 - 2018-06-12](https://www.keypedia.com/records/fda_inspections/vitalant/52195060-f01d-44d1-81a0-b0fc614886d8)
- [FDA Inspection 906172 - 2014-12-03](https://www.keypedia.com/records/fda_inspections/vitalant/0389e37e-6b2e-4ca7-b403-ad5011118243)
- [FDA Inspection 844028 - 2013-07-31](https://www.keypedia.com/records/fda_inspections/vitalant/60c79b2b-4bad-4488-aeb1-ea6f79817f0d)

Company: https://www.keypedia.com/companies/vitalant/b7e1095a-0f8d-46cd-b6e3-296e18fe9f5c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d